How can high-throughput screening deliver drugs to treat atherosclerosis?
Published 2010 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
How can high-throughput screening deliver drugs to treat atherosclerosis?
Authors
Keywords
-
Journal
Expert Opinion on Drug Discovery
Volume 5, Issue 12, Pages 1175-1188
Publisher
Informa Healthcare
Online
2010-11-20
DOI
10.1517/17460441.2010.529896
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Antiatherogenic Functionality of High Density Lipoprotein: How Much versus How Gooden-subtitle=
- (2011) Dmitri Sviridov et al. Journal of Atherosclerosis and Thrombosis
- Identification of two antagonists of the scavenger receptor CD36 using a high-throughput screening model
- (2010) Yanni Xu et al. ANALYTICAL BIOCHEMISTRY
- Design, synthesis, and cholesterol-lowering efficacy for prodrugs of berberrubine
- (2010) Ying-Hong Li et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Future Therapeutic Directions in Reverse Cholesterol Transport
- (2010) Amit V. Khera et al. Current Atherosclerosis Reports
- Advancing therapy for hypercholesterolemia
- (2010) Konstantinos Toutouzas et al. EXPERT OPINION ON PHARMACOTHERAPY
- RVX-208
- (2010) Dana Bailey et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- The Pharmacology and Off-Target Effects of Some Cholesterol Ester Transfer Protein Inhibitors
- (2009) Menno Vergeer et al. AMERICAN JOURNAL OF CARDIOLOGY
- The Molecular Target of Rubimaillin in the Inhibition of Lipid Droplet Accumulation in Macrophages
- (2009) Daisuke Matsuda et al. BIOLOGICAL & PHARMACEUTICAL BULLETIN
- Synthesis and biological evaluation of berberine analogues as novel up-regulators for both low-density-lipoprotein receptor and insulin receptor
- (2009) Yan-Xiang Wang et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Design and synthesis of potent inhibitors of cholesteryl ester transfer protein (CETP) exploiting a 1,2,3,4-tetrahydroquinoline platform
- (2009) Thomas A. Rano et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- 2-Arylbenzoxazoles as CETP inhibitors: Substitution of the benzoxazole moiety
- (2009) Cameron J. Smith et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- An Unbiased Chemical Biology Screen Identifies Agents That Modulate Uptake of Oxidized LDL by Macrophages
- (2009) Yoram Etzion et al. CIRCULATION RESEARCH
- Squalene synthase: a critical enzyme in the cholesterol biosynthesis pathway
- (2009) R Do et al. CLINICAL GENETICS
- Anti-atherosclerotic Activity of Triacsin C, an Acyl-CoA Synthetase Inhibitor
- (2009) Daisuke Matsuda et al. JOURNAL OF ANTIBIOTICS
- Pentacecilides, new inhibitors of lipid droplet formation in mouse macrophages produced by Penicillium cecidicola FKI-3765-1: II. Structure elucidation
- (2009) Hiroyuki Yamazaki et al. JOURNAL OF ANTIBIOTICS
- Safety, Pharmacokinetics, and Pharmacodynamics of Single Doses of LXR-623, a Novel Liver X-Receptor Agonist, in Healthy Participants
- (2009) Arie Katz et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Design, Synthesis, and Biological Evaluation of (2R,αS)-3,4-Dihydro-2-[3-(1,1,2,2-tetrafluoroethoxy)phenyl]-5-[3-(trifluoromethoxy)-phenyl]-α-(trifluoromethyl)-1(2H)-quinolineethanol as Potent and Orally Active Cholesteryl Ester Transfer Protein Inhibitor
- (2009) Gee-Hong Kuo et al. JOURNAL OF MEDICINAL CHEMISTRY
- Effect of the dual peroxisome proliferator-activated receptor-α/γ agonist aleglitazar on risk of cardiovascular disease in patients with type 2 diabetes (SYNCHRONY): a phase II, randomised, dose-ranging study
- (2009) Robert R Henry et al. LANCET
- Liver X Receptor Activation Induces the Uptake of Cholesteryl Esters From High Density Lipoproteins in Primary Human Macrophages
- (2008) Stephanie Bultel et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Potent and Selective PPAR-α Agonist LY518674 Upregulates Both ApoA-I Production and Catabolism in Human Subjects With the Metabolic Syndrome
- (2008) John S. Millar et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Identification of trichostatin A as a novel transcriptional up-regulator of scavenger receptor BI both in HepG2 and RAW 264.7 cells
- (2008) Yi Bao et al. ATHEROSCLEROSIS
- Molecular Target of Piperine in the Inhibition of Lipid Droplet Accumulation in Macrophages
- (2008) Daisuke Matsuda et al. BIOLOGICAL & PHARMACEUTICAL BULLETIN
- Synthesis and structure–activity relationships of berberine analogues as a novel class of low-density-lipoprotein receptor up-regulators
- (2008) Peng Yang et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Discovery of potent, selective sulfonylfuran urea endothelial lipase inhibitors
- (2008) Krista B. Goodman et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- The Cholesterol Absorption Inhibitor Ezetimibe Acts by Blocking the Sterol-Induced Internalization of NPC1L1
- (2008) Liang Ge et al. Cell Metabolism
- Berberine Analogues as a Novel Class of the Low-Density-Lipoprotein Receptor Up-Regulators: Synthesis, Structure−Activity Relationships, and Cholesterol-Lowering Efficacy
- (2008) Ying-Hong Li et al. JOURNAL OF MEDICINAL CHEMISTRY
- The Statins in Preventive Cardiology
- (2008) Daniel Steinberg NEW ENGLAND JOURNAL OF MEDICINE
- Identifying Natural Derived Upregulators of Human ApoA-I Expression via a Cell-Based Drug Screening System
- (2008) Ting Deng et al. PHARMACEUTICAL BIOLOGY
- Traditional Chinese Medicine in Treatment of Metabolic Syndrome
- (2008) Jun Yin et al. Endocrine Metabolic & Immune Disorders-Drug Targets
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now